Skip to main content

Table 3 Annual average direct costs by number of headache days per month

From: Economic consequences of migraine in Sweden and implications for the cost-effectiveness of onabotulinumtoxinA (Botox) for chronic migraine in Sweden and Norway

Headache days per month Direct costs (EUR)
Healthcare utilization Drug treatments Total
0–4 headache days 805 311 1116
5–9 headache days 1707 660 2368
10–14 headache days 1500 1181 2681
15–24 headache days 2312 1697 4009
25–31 headache days 2942 2370 5311